1. Home
  2. LOOP vs TCRX Comparison

LOOP vs TCRX Comparison

Compare LOOP & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Loop Industries Inc.

LOOP

Loop Industries Inc.

HOLD

Current Price

$1.25

Market Cap

59.5M

Sector

Industrials

ML Signal

HOLD

Logo TScan Therapeutics Inc.

TCRX

TScan Therapeutics Inc.

HOLD

Current Price

$0.96

Market Cap

64.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOOP
TCRX
Founded
2010
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.5M
64.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
LOOP
TCRX
Price
$1.25
$0.96
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$8.50
AVG Volume (30 Days)
53.7K
468.7K
Earning Date
01-14-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,146,000.00
$8,423,000.00
Revenue This Year
N/A
$286.83
Revenue Next Year
$174.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
8746.03
N/A
52 Week Low
$0.85
$0.88
52 Week High
$2.29
$2.57

Technical Indicators

Market Signals
Indicator
LOOP
TCRX
Relative Strength Index (RSI) 62.74 38.60
Support Level $1.15 $0.91
Resistance Level $1.30 $1.04
Average True Range (ATR) 0.07 0.07
MACD 0.00 -0.01
Stochastic Oscillator 79.17 15.43

Price Performance

Historical Comparison
LOOP
TCRX

About LOOP Loop Industries Inc.

Loop Industries Inc. is a technology and licensing company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. The company owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any color, transparency or condition, and even ocean plastics that have been degraded by the sun and salt, to its base building blocks.

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

Share on Social Networks: